UNSPSC 51131821: Coagulation factor viii

This classification denotes an antifibrinolytic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5T6B772R4Q. European Medicines Agency schedules Coagulation factor viii in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13813MIG. Coagulation factor viii bears US NLM identifiers UMLS ID C0015506 and NCI Concept Code C16571.

UNSPSC 51131821 Coagulation factor VIII is a Commodity code for blood coagulation products used in hemophilia treatment and other bleeding disorders. State and local governments procure this product primarily through health departments, corrections facilities, public hospitals, and emergency medical services to support patient care and inmate medical programs. The code covers factor VIII concentrate in various formulations — recombinant and plasma-derived — and the related infusion supplies needed for administration.

The recent opportunities block contains no solicitations aligned with coagulation factor VIII procurement. The single recent posting under this code, Sourcewell RFP #061626 issued May 12, 2026 with a June 16 response deadline, solicits law enforcement equipment on behalf of multiple Washington counties and a nationwide cooperative of public entities. This posting represents a clear mismatch with the code's nominal scope and does not reflect actual state and local procurement activity for coagulation factor VIII.